AlainBouchardMD
Cardiology • Birmingham, ALEchocardiography, Non-Invasive Cardiology, Preventive Cardiology
Physician
Dr. Bouchard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2700 10th Ave
Birmingham, AL 35205Phone+1 205-939-7100Fax+1 205-939-7101
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1983 - 1986
University of Laval Faculty of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1983 - Present
AL State Medical License 1986 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
National Board of Physicians and Surgeons Cardiovascular Disease- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts MyWay EHR, Allscripts, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) Start of enrollment: 2015 Apr 01
Publications & Presentations
PubMed
- 34 citationsRandomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.Emerson C Perin, Kenneth M Borow, Timothy D Henry, Farrell O Mendelsohn, Leslie W Miller
Journal of the American College of Cardiology. 2023-03-07 - 57 citationsThe REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of HypertensionMichael A. Weber, SM Ajay J. Kirtane Md, Matthew R. Weir, Jai Radhakrishnan, Tony Das
JACC. Cardiovascular Interventions. 2020-02-24 - 20 citationsLong-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.Christopher R. Kelly, Paul S. Teirstein, Ian T. Meredith, Bruno Farah, Christophe Dubois
JACC. Cardiovascular Interventions. 2017-12-11
Press Mentions
St. Vincent’s Conducting Phase III Trial for New Anticoagulant TreatmentsDecember 21st, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
